Therapeutic proteins and nanotechnology: immune response and stealth bioengineered constructs

Area of Science:

• Biomedicine
• Immunology
• Pharmacology

Background:

• Intravenous drug administration is vital for organ delivery and targeting.
• Rapid clearance by circulating immune cells limits drug efficacy and bioavailability.
• Understanding drug-immune cell interactions is crucial for optimizing drug delivery systems.

Purpose of the Study:

• To review immune mechanisms of drug clearance after systemic delivery.
• To highlight the role of drug surface chemistry and size in immune response.
• To explore strategies for evading immune surveillance and enhancing drug bioavailability.

Main Methods:

• Literature review of classical and novel immune pathways involved in drug clearance.
• Analysis of drug surface properties (chemistry, size) influencing immune cell interactions.
• Examination of polymer-grafting techniques, particularly Poly(Ethylene Glycol) (PEG)ylation.
• Overview of advanced strategies like "smart shields" for controlled drug release.

Main Results:

• Drug surface properties significantly impact immune cell recognition and clearance.
• Polymer-grafting, especially with PEG, is a common strategy to reduce immune surveillance.
• PEGylation can enhance drug circulation half-life and improve bioavailability.
• Smart shields offer tunable control over drug release and pharmacokinetics.

Conclusions:

• Modifying drug surfaces is essential for overcoming immune-mediated clearance after intravenous administration.
• Poly(Ethylene Glycol) (PEG)ylation is a versatile strategy for improving drug delivery and bioavailability.
• Advanced techniques like smart shields show promise for balancing drug circulation time and therapeutic efficacy.